Corprate Bias Ratings
Alnylam Pharmaceuticals vets vendors for LGBTQ policies and does not provide viewpoint protections for its employees. However, it has not publicly terminated business relationships based on views or beliefs. Its CEO signed the CEO Action for Diversity & Inclusion pledge, which includes a commitment to promote DEI through bias education training in the workplace. Alnylam frequently uses its reputation to promote LGBTQ Pride. However, it does not discriminate against religious organizations in its charitable giving and has not used its corporate funds or lobbied for ideological purposes. For these reasons, Alnylam Pharmaceuticals receives a Medium Risk rating.
Has denied service to customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
Alnylam Pharmaceuticals has a written policy pledging to vet vendors for LGBTQ policies. Its Code of Business Conduct and Ethics requires vendors to include sexual orientation and gender identity in their nondiscrimination policy (1). However, Alnylam Pharmaceuticals has not publicly fired customers, suppliers, or vendors based on political views or religious beliefs.
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
Uses corporate reputation to support ideological causes and/or organizations hostile to freedom of expression.
Alnylam Pharmaceuticals CEO signed the CEO Action for Diversity & Inclusion pledge, which includes a commitment to promote DEI through bias education training in the workplace (1). Alnylam featured multiple blog posts on its website highlighting its celebration of LGBTQ Pride Month and publicized its participation in the Boston Pride Parade on its website and Facebook account (2)(3)(4). Alnylam posted to its corporate Facebook account in celebration of LGBTQ Pride Month and changed its profile picture to a Pride logo for the month of June (5)(6). Alnylam released a statement following George Floyd’s death, including a statement from its CEO (7).
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
Alnylam Pharmaceuticals has not used corporate funds to advance ideological causes, organizations, or policies (1).
All links were last accessed and all information was updated on:
November 2, 2023
Company reports are intended for educational use only. Full Disclaimer